Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adenocarcinoma of the gastroesophageal junction
|
6 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Atherogenic dyslipidaemia
|
9 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
Autonomic neuropathy
|
7 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Carcinoma of lung
|
1204 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Cholangiocarcinoma
|
43 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Chronic kidney disease stage 5
|
194 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Constitutional obesity
|
3 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
Cystic Fibrosis
|
704 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
Diabetes in youth
|
2 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
Diabetic foot ulcer
|
17 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Dyslipidemias
|
184 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Familial obesity
|
3 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
Glioma
|
353 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Hepatitis C
|
347 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Hereditary Multiple Exostoses
|
51 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Human immunodeficiency virus (HIV) II infection category B1
|
56 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Hyperlipidemia, Familial Combined
|
28 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
Hypertensive disease
|
1085 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Ischemic stroke
|
704 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Kidney Failure, Chronic
|
425 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Large-artery atherosclerosis (embolus/thrombosis)
|
35 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Malignant neoplasm of lung
|
1142 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Malignant neoplasm of pancreas
|
277 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Malignant neoplasm of stomach
|
615 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
metabolic disturbance
|
4 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2015 | 2015 |